Word

CERVATEC

Status

Dead

Status Code

710

Status Date

Friday, December 4, 2015

Serial Number

78890411

Registration Number

3612481

Registration Date

Tuesday, April 28, 2009

Mark Type

4000

Filing Date

Tuesday, May 23, 2006

Published for Opposition

Tuesday, March 25, 2008

Cancellation Date

Friday, December 4, 2015

Trademark Owner History

ROCHE MTM LABORATORIES AG -
MTM Laboratories AG - Original Registrant

Classifications

1 diagnostic preparations, reagents for scientific and medical research use, and chemical test kits comprised of reagents for chemical analyses and reagents for medical research use for detection of cancerous conditions, neoplastic conditions, inflammatory conditions, infectious conditions, degenerative conditions, genetically aberrant or diseased conditions, proliferatively aberrant or diseased conditions, vascular disease conditions, premalignant conditions, malignant conditions, cancer and inborn errors for scientific or research use

5 veterinary preparations for the treatment and prevention of neoplastic, inflammatory, infectious, degenerative, genetic and proliferative and vascular diseases and for the treatment of premalignant and malignant cancerous conditions, cancer and inborn errors in livestock, cattle, pigs, horses, deer, elk, moose, sheep, dogs, cats, mice, rats, monkeys, apes and birds; medical diagnostic reagents and kits comprised of medical diagnostic reagents and assays for detection of cancer and neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases and for the detection of premalignant and malignant cancerous conditions, cancer and inborn errors; medical diagnostic preparations, namely, in-vitro and in-vivo diagnostic test kits comprised of medical diagnostic reagents and assays, diagnostic immunocytochemical kits comprised of medical diagnostic reagents and assays, diagnostic immunohistochemical kits comprised of medical diagnostic reagents and assays, diagnostic histology kits comprised of medical diagnostic reagents and assays, diagnostic cytology kits comprised of medical diagnostic reagents and assays, diagnostic liquid-immuno-assay kits comprised of medical diagnostic reagents and assays, diagnostic solid-phase immuno-assay kits comprised of medical diagnostic reagents and assays, point of care test kits comprised of medical diagnostic reagents and assays, diagnostic lateral-flow assay kits comprised of medical diagnostic reagents and assays, diagnostic flow-through assay kits comprised of medical diagnostic reagents and assays, diagnostic immuno-chromatographic kits comprised of medical diagnostic reagents and assays, all of the above-mentioned kits being for use in early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious, genetic, proliferative or vascular diseases; medical diagnostic test strips and diagnostic dip-stick tests for use in early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious, genetic, proliferative or vascular diseases

10 diagnostic testing machines, namely, point-of-care testing machines for immunochemistry testing, medical diagnostic liquid-immuno-assay machines, medical diagnostic immunocytochemical machines, medical diagnostic immunohistochemical machines, medical diagnostic histology machines, medical diagnostic cytology machines, medical diagnostic solid-phase immuno assay machines, medical diagnostic ELISA testing machines, medical diagnostic immuno-chromatographic machines; diagnostic nucleic acid detection machines, diagnostic nucleic acid amplification machines, diagnostic immuno-histology machines and diagnostic immuno-cytology machines, all of the aforementioned machines being used to analyze and provide diagnostic test results and used in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious and genetic diseases associated with cancer, proliferative diseases associated with neoplastics and dysplastic conditions or vascular diseases; diagnostic equipment, apparatuses and instruments, namely, containers for medical samples, vessels, namely, containers specially designed for storing and transporting medical samples, brushes, namely, for sampling of medical samples from body cavities and epithelia; medical syringes, needles for medical use, spatulas, namely, for medical samples and medical diagnostic testing, all for use in sampling, storing, transporting, preparing, enriching, concentrating, testing, analyzing and evaluating of biological material and samples in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer and inborn errors

42 scientific analysis in the fields of chemistry, biology and molecular biology; laboratory research in the field of molecular biology; laboratory research in the fields of pharmaceutics and food technology; providing pharmaceutical research services, chemical research services, and medical diagnostic research services; research and development of pharmaceutical products and substances for others; scientific research in the nature of scientific information research services; chemical, biological, molecular biology and pharmacogenomic analysis services

44 medical diagnostic services and provision of medical diagnostic information in the field of detection of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn errors, detection of neoplastic, inflammatory, infectious, degenerative, genetic and proliferative and vascular diseases; veterinary diagnostic services and provision of veterinary diagnostic information in the field of detection of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn errors, detection of neoplastic, inflammatory, infectious, degenerative, genetic and proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn errors in livestock, cattle, pigs, horses, deer, elk, moose, sheep, dogs, cats, mice, rats, monkeys, apes and birds

Trademark Events

Dec 4, 2015

Cancelled Sec. 8 (6-Yr)

Mar 24, 2014

Withdrawal Of Attorney Granted

Mar 24, 2014

Teas Withdrawal Of Attorney Received

Apr 20, 2012

Attorney Revoked And/Or Appointed

Apr 20, 2012

Teas Revoke/Appoint Attorney Received

Apr 18, 2012

Automatic Update Of Assignment Of Ownership

Apr 28, 2009

Registered-Principal Register

Mar 23, 2009

1(B) Basis Deleted; Proceed To Registration

Mar 20, 2009

Notice Of Allowance Cancelled

Mar 23, 2009

Case Assigned To Intent To Use Paralegal

Mar 20, 2009

Teas Delete 1(B) Basis Received

Sep 23, 2008

Noa Mailed - Sou Required From Applicant

Aug 8, 2008

Extension Of Time To Oppose Process - Terminated

Apr 15, 2008

Extension Of Time To Oppose Received

Mar 25, 2008

Published For Opposition

Mar 5, 2008

Notice Of Publication

Feb 21, 2008

Law Office Publication Review Completed

Feb 20, 2008

Approved For Pub - Principal Register

Feb 19, 2008

Examiner's Amendment Entered

Feb 19, 2008

Notification Of Examiners Amendment E-Mailed

Feb 19, 2008

Examiners Amendment E-Mailed

Feb 19, 2008

Examiners Amendment -Written

Jan 29, 2008

Teas/Email Correspondence Entered

Jan 28, 2008

Correspondence Received In Law Office

Jan 28, 2008

Teas Request For Reconsideration Received

Jul 27, 2007

Notification Of Final Refusal Emailed

Jul 27, 2007

Final Refusal E-Mailed

Jul 27, 2007

Final Refusal Written

Jul 6, 2007

Teas/Email Correspondence Entered

Jul 6, 2007

Correspondence Received In Law Office

Jul 5, 2007

Assigned To Lie

Jun 27, 2007

Teas Response To Office Action Received

Jun 27, 2007

Petition To Revive-Granted

Jun 27, 2007

Teas Petition To Revive Received

May 31, 2007

Abandonment Notice Mailed - Failure To Respond

May 31, 2007

Abandonment - Failure To Respond Or Late Response

Oct 25, 2006

Non-Final Action E-Mailed

Oct 25, 2006

Non-Final Action Written

Oct 24, 2006

Assigned To Examiner

May 31, 2006

New Application Entered In Tram